Literature DB >> 3544908

Zinc metabolism in alcoholic liver disease.

C J McClain, D R Antonow, D A Cohen, S I Shedlofsky.   

Abstract

Alterations in zinc metabolism or zinc deficiency frequently occur in patients with alcoholic liver disease. Potential manifestations of zinc deficiency include skin lesions, hypogonadism, impaired night vision, impaired immune function, anorexia, altered protein metabolism, diarrhea, and depressed mental function. Because of the variety of ways in which zinc deficiency may present in alcoholic liver disease, clinicians must maintain a high index of suspicion for this nutrient deficiency when caring for these patients. Not only may zinc deficiency occur with alcoholic liver disease, but there also may be altered zinc metabolism. Recent data from alcoholic hepatitis patients demonstrate increased serum levels of the monokine interleukin 1, which is known to cause hypozincemia and an internal redistribution of zinc. This monokine has a host of metabolic functions other than its effect on mineral metabolism that have relevance for alcoholic liver disease such as fever production, neutrophilia, and muscle catabolism. We suggest that the patient with alcoholic liver disease frequently has problems with either zinc deficiency or altered zinc metabolism and the potential implications of this are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3544908     DOI: 10.1111/j.1530-0277.1986.tb05149.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  31 in total

Review 1.  Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?

Authors:  Akshata Moghe; Swati Joshi-Barve; Smita Ghare; Leila Gobejishvili; Irina Kirpich; Craig J McClain; Shirish Barve
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

Review 3.  Protein acetylation in metabolism - metabolites and cofactors.

Authors:  Keir J Menzies; Hongbo Zhang; Elena Katsyuba; Johan Auwerx
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

4.  Pharmacokinetic study of orally administered zinc in humans: evidence for an enteral recirculation.

Authors:  J Nève; M Hanocq; A Peretz; F Abi Khalil; F Pelen; J P Famaey; J Fontaine
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

5.  Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.

Authors:  Xinqin Kang; Wei Zhong; Jie Liu; Zhenyuan Song; Craig J McClain; Y James Kang; Zhanxiang Zhou
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

6.  Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease.

Authors:  K Grønbaek; H Friis; M Feldman; J Sonne; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

7.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 8.  Role of Zinc in the Development/Progression of Alcoholic Liver Disease.

Authors:  Craig McClain; Vatsalya Vatsalya; Matthew Cave
Journal:  Curr Treat Options Gastroenterol       Date:  2017-06

9.  Effect of zinc intake on hepatic autophagy during acute alcohol intoxication.

Authors:  Juan P Liuzzi; Vijaya Narayanan; Huong Doan; Changwon Yoo
Journal:  Biometals       Date:  2018-02-01       Impact factor: 2.949

10.  Zinc supplementation enhances hepatic regeneration by preserving hepatocyte nuclear factor-4alpha in mice subjected to long-term ethanol administration.

Authors:  Xinqin Kang; Zhenyuan Song; Craig J McClain; Y James Kang; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.